Two Wolf Greenfield Attorneys Recognized as IAM Global Leaders 2025

Ed Gates and Scott McKeown were recognized on the list of IAM Global Leaders 2025. To qualify for inclusion in the IAM Global Leaders, individuals must be ranked in the gold tier of the IAM Patent 1000, a market-leading annual directory that identifies the top law and attorney firms and individuals in the world’s most significant patent jurisdictions. From this group, IAM selects candidates for IAM Global Leaders who “merit special attention – not only because of their experience related to creating, protecting, managing, transacting, and enforcing critical patent rights, but also for their ability to innovate, inspire, and go above and beyond to deliver value for their clients.”

Ed Gates, a shareholder in Wolf Greenfield’s Biotechnology Practice and Pharmaceutical Practice, serves pharmaceutical, biotechnology, and medical device companies of all sizes and at all stages of development. Ed’s practice spans licensing, post-grant proceedings, patent portfolio development, counseling, and litigation. His extensive licensing experience places him in the elite of IP transaction lawyers. Ed’s practice in recent years has focused on inter partes review, post grant review, and contract disputes in arbitrations and federal court litigation. Ed’s more than 35 years of experience helps him recognize and capture value at the intersection of technology, intellectual property, and business. He has represented clients from start-ups to fortune 100 companies. Ed is perennially recognized by ranking organizations such as Chambers, Best Lawyers in America, Super Lawyers (among many others) for his skills.

Scott McKeown, a shareholder in Wolf Greenfield’s Post-Grant Proceedings Practice, focuses his practice on post-grant patent counseling and litigation matters at the US Patent and Trademark Office and related appeals to the US Court of Appeals for the Federal Circuit. Scott handles all aspects of post-issuance patent proceedings, with a particular focus on administrative trials before the Patent Trial and Appeal Board, such as inter partes review and post-grant review. He also provides advice on USPTO post-grant proceedings concurrent with complex International Trade Commission and district court litigations. Named one of the world’s leading patent practitioners for post-grant proceedings by IAM, Scott is one of the most active PTAB trial attorneys in the US, having handled more than 400 PTAB matters since 2012, including those in which more than $500 million was at stake. He currently serves as lead post-grant counsel to some of the world’s best-known innovators and has handled some of the most noteworthy PTAB trials to date, and a Professorial Lecturer in Law at The George Washington University Law School. Moreover, he was named by Managing IP as its “Outstanding PTAB Litigator” in 2020.